These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 16932675)

  • 21. Inflammation-responsive promoters for fine-tuned gene therapy in rheumatoid arthritis.
    van de Loo FA
    Curr Opin Mol Ther; 2004 Oct; 6(5):537-45. PubMed ID: 15537055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Animal models of rheumatoid arthritis. Clues to etiology and treatment.
    Brahn E
    Clin Orthop Relat Res; 1991 Apr; (265):42-53. PubMed ID: 2009677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular and genetic therapies for haemophilia.
    Lillicrap D; VandenDriessche T; High K
    Haemophilia; 2006 Jul; 12 Suppl 3():36-41. PubMed ID: 16683995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apoptosis as a therapeutic tool in rheumatoid arthritis.
    Pope RM
    Nat Rev Immunol; 2002 Jul; 2(7):527-35. PubMed ID: 12094227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene therapeutic approaches-transfer in vivo.
    Evans CH; Gouze E; Gouze JN; Robbins PD; Ghivizzani SC
    Adv Drug Deliv Rev; 2006 May; 58(2):243-58. PubMed ID: 16563557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene therapy for arthritis.
    Robbins PD; Evans CH; Chernajovsky Y
    Gene Ther; 2003 May; 10(10):902-11. PubMed ID: 12732875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The promise of a new clinical trial--intra-articular IL-1 receptor antagonist.
    Evans CH; Robbins PD
    Proc Assoc Am Physicians; 1996 Jan; 108(1):1-5. PubMed ID: 8834057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnosis and therapy monitoring applying methods of molecular medicine].
    Kekow J; Drynda S
    Z Rheumatol; 2002; 61 Suppl 2():II/6-9. PubMed ID: 12491115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Barriers to gene delivery using synthetic vectors.
    Read ML; Logan A; Seymour LW
    Adv Genet; 2005; 53():19-46. PubMed ID: 16240989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Gene therapy for rheumatoid arthritis by apoptosis-related gene transfer].
    Kobayashi T; Okamoto K; Nishioka K
    Nihon Rinsho Meneki Gakkai Kaishi; 2000 Dec; 23(6):543-6. PubMed ID: 11210739
    [No Abstract]   [Full Text] [Related]  

  • 31. Cationic liposome formulations for RNAi-based validation of therapeutic targets in rheumatoid arthritis.
    Presumey J; Duroux-Richard I; Courties G; Apparailly F
    Curr Opin Mol Ther; 2010 Jun; 12(3):325-30. PubMed ID: 20521221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis.
    Müller-Ladner U; Pap T; Gay RE; Neidhart M; Gay S
    Nat Clin Pract Rheumatol; 2005 Dec; 1(2):102-10. PubMed ID: 16932639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors underlying chronic inflammation in rheumatoid arthritis.
    Wong SH; Lord JM
    Arch Immunol Ther Exp (Warsz); 2004; 52(6):379-88. PubMed ID: 15577739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The usefulness and the limitations of animal models in identifying targets for therapy in arthritis.
    Wooley PH
    Best Pract Res Clin Rheumatol; 2004 Feb; 18(1):47-58. PubMed ID: 15123037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis.
    Terzioglu E; Bisgin A; Sanlioglu AD; Ulker M; Yazisiz V; Tuzuner S; Sanlioglu S
    Rheumatology (Oxford); 2007 May; 46(5):783-9. PubMed ID: 17309888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study.
    Mease PJ; Hobbs K; Chalmers A; El-Gabalawy H; Bookman A; Keystone E; Furst DE; Anklesaria P; Heald AE
    Ann Rheum Dis; 2009 Aug; 68(8):1247-54. PubMed ID: 18678578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene transfer strategies for metabolic diseases.
    Raper SE; McClane SJ
    World J Surg; 2002 Jul; 26(7):838-42. PubMed ID: 11965443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Animal models of arthritis caused by systemic alteration of the immune system.
    Sakaguchi S; Sakaguchi N
    Curr Opin Immunol; 2005 Dec; 17(6):589-94. PubMed ID: 16214319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic therapies for cardiovascular diseases.
    Melo LG; Pachori AS; Gnecchi M; Dzau VJ
    Trends Mol Med; 2005 May; 11(5):240-50. PubMed ID: 15882612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progress and potential for gene-based medicines.
    Dyer MR; Herrling PL
    Mol Ther; 2000 Mar; 1(3):213-24. PubMed ID: 10933937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.